Your browser doesn't support javascript.
loading
A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC.
Rao, Zuqin; Li, Heng; Yao, Wenchao; Wang, Qiang; Ma, Biao; Xue, Dongbo; Meng, Xianzhi.
Affiliation
  • Rao Z; Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li H; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Yao W; Department of Comprehensive Surgery, The First Affiliated Hospital of University of Science and Technology of China (USTC) West District/Anhui Provincial Cancer Hospital, Hefei, China.
  • Wang Q; Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Ma B; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Xue D; Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Meng X; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Front Oncol ; 12: 927468, 2022.
Article in En | MEDLINE | ID: mdl-35965499

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: